This major PHSS conference will address the key challenges in sterile product manufacture and processing of intermediates that require low bioburden control following risk based initiatives from a regulatory, Pharmaceutical/ Bio-pharmaceutical industry and healthcare pharmacy perspective.
More details to follow shortly
Head of pharmacy at Hammersmith Medicines Research Ltd
Company Director & Senior Consultant of ExPharmaceutical Inspectors Consortium Ltd